APA (7th ed.) Citation

Li, X., Fan, M., Huang, R., Wang, K., & Huang, H. Liraglutide inhibits the development of colorectal cancer by regulating TGF-β/Smad3 signaling pathway and affecting epithelial-mesenchymal transition. Springer.

Chicago Style (17th ed.) Citation

Li, Xinjian, Minghu Fan, Rong Huang, Keqiang Wang, and Hunan Huang. Liraglutide Inhibits the Development of Colorectal Cancer by Regulating TGF-β/Smad3 Signaling Pathway and Affecting Epithelial-mesenchymal Transition. Springer.

MLA (9th ed.) Citation

Li, Xinjian, et al. Liraglutide Inhibits the Development of Colorectal Cancer by Regulating TGF-β/Smad3 Signaling Pathway and Affecting Epithelial-mesenchymal Transition. Springer.